CIPLA LTD. - 500087 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we herein mention the schedule of Analyst / Institutional Investor Meetings with the Company. CIPLA LTD. - 500087 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) and other applicable regulations of SEBI listing Regulations, 2015, we would like to inform you that the registrar and share agent of company M/S KFin Technologies Limited has received intimation for loss of shares certificates and request for issuance of duplicate share certificates
Cipla Share Price Live blog for 30 Nov 2023
Cipla stock price went up today, 30 Nov 2023, by 0.96 %. The stock closed at 1192.05 per share. The stock is currently trading at 1203.55 per share. Investors should monitor Cipla stock price closely in the coming days and weeks to see how it reacts to the news. CIPLA LTD. - 500087 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to regulation 39(3) and other applicable regulations of SEBI Listing regulations, 2015, we would like to inform you that Registrar and Share Transfer Agent of company M/S KFin Technologies Limited has received intimation for loss of share certificates and request for issuance of duplicate share certificates
Cipla faces downgrade after USFDA warning letter
B&K Securities airs concerns considering Cipla's significant exposure to the US market, constituting 28% of consolidated sales Cipla Share Price Live blog for 29 Nov 2023
Cipla stock price went down today, 29 Nov 2023, by -0.57 %. The stock closed at 1198.85 per share. The stock is currently trading at 1192.05 per share. Investors should monitor Cipla stock price closely in the coming days and weeks to see how it reacts to the news. CIPLA LTD. - 500087 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we herein mention the schedule of Analyst / Institutional Investor Meetings with the Company. CIPLA LTD. - 500087 - Update On Acquisition Of Additional Stake In Cipla Maroc SA
Update on acquisition of additional stake in Cipla Maroc SA, Morocco
Cipla share price rises more than 3%: overhang of USFDA warning letter for its Pithampur facility still remains.
Stock Market Today- Cipla's Pithampur, manufacturing facility receiving warning letter has added to concerns over respiratory products Albuterol generic US supplies and delay in launch of Advair generic. Currently Revlimid generics are supporting US sales growth but large product launch is critical